D'ERRICO, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 18.737
AS - Asia 17.745
EU - Europa 11.437
AF - Africa 1.019
SA - Sud America 918
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 11
Totale 49.897
Nazione #
US - Stati Uniti d'America 18.466
VN - Vietnam 5.471
SG - Singapore 4.584
CN - Cina 4.129
GB - Regno Unito 2.482
IT - Italia 2.180
DE - Germania 1.479
SE - Svezia 1.307
HK - Hong Kong 1.202
FR - Francia 821
IN - India 724
BR - Brasile 688
RU - Federazione Russa 600
IE - Irlanda 457
NL - Olanda 439
UA - Ucraina 382
FI - Finlandia 317
KR - Corea 311
BD - Bangladesh 277
ZA - Sudafrica 262
JP - Giappone 251
CI - Costa d'Avorio 230
TG - Togo 223
CH - Svizzera 210
EE - Estonia 167
CA - Canada 158
JO - Giordania 144
SC - Seychelles 140
BG - Bulgaria 116
AR - Argentina 111
BE - Belgio 101
PH - Filippine 99
TH - Thailandia 85
AT - Austria 83
ID - Indonesia 82
NG - Nigeria 73
MX - Messico 66
PL - Polonia 65
TR - Turchia 55
IQ - Iraq 54
TW - Taiwan 50
ES - Italia 47
IR - Iran 36
PK - Pakistan 33
UZ - Uzbekistan 31
EC - Ecuador 29
SA - Arabia Saudita 28
GR - Grecia 26
AU - Australia 24
HR - Croazia 23
MY - Malesia 23
RO - Romania 23
CL - Cile 19
CO - Colombia 19
MA - Marocco 19
DK - Danimarca 16
LT - Lituania 16
PT - Portogallo 16
EG - Egitto 15
PE - Perù 13
PY - Paraguay 13
LB - Libano 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
AZ - Azerbaigian 10
KE - Kenya 9
KZ - Kazakistan 9
CR - Costa Rica 8
MD - Moldavia 8
DZ - Algeria 7
ET - Etiopia 7
EU - Europa 7
SI - Slovenia 7
TN - Tunisia 7
AL - Albania 6
DO - Repubblica Dominicana 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
GH - Ghana 5
HN - Honduras 5
MK - Macedonia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
GD - Grenada 4
GT - Guatemala 4
NP - Nepal 4
AO - Angola 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
SN - Senegal 3
Totale 49.839
Città #
Singapore 3.119
Southend 2.122
Ashburn 2.091
Fairfield 1.559
Chandler 1.365
Ho Chi Minh City 1.218
Hong Kong 1.138
Hanoi 1.052
San Jose 1.018
Woodbridge 839
Houston 785
Dong Ket 753
Wilmington 720
Hefei 714
Seattle 693
Santa Clara 687
Princeton 575
Cambridge 562
Ann Arbor 536
Bologna 534
Beijing 507
Dublin 455
Boardman 392
Los Angeles 357
Dallas 339
Lauterbourg 321
Seoul 266
Helsinki 263
New York 262
Abidjan 230
Lomé 223
Tokyo 216
Westminster 209
Nanjing 207
Council Bluffs 203
Jacksonville 190
Berlin 186
Haiphong 186
Padova 186
Bern 172
Da Nang 170
Amman 140
Buffalo 139
Jinan 136
São Paulo 128
Frankfurt am Main 125
Milan 124
Saint Petersburg 118
Bremen 113
Redondo Beach 111
Sofia 111
San Diego 110
Munich 104
Turin 96
Shenyang 95
Guangzhou 93
Brussels 92
Redmond 84
Rome 82
Changsha 79
Nanchang 79
Shanghai 78
Tianjin 76
Florence 75
Hebei 75
Johannesburg 69
Biên Hòa 67
Chicago 64
Dearborn 64
Bengaluru 62
Orem 62
Can Tho 61
Phoenix 60
San Francisco 60
Hải Dương 59
Abeokuta 58
Medford 58
Toronto 56
London 55
Des Moines 53
Redwood City 52
Zhengzhou 52
Mülheim 51
Hangzhou 50
Amsterdam 48
Denver 46
Jakarta 46
Falkenstein 45
Thái Nguyên 45
Brooklyn 43
Jiaxing 43
Montreal 42
Paris 42
Quận Bình Thạnh 42
Nuremberg 40
Vũng Tàu 40
Warsaw 40
Atlanta 39
Vienna 38
Ninh Bình 36
Totale 31.871
Nome #
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 651
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 636
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 499
Ulcerative Colitis 372
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 339
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 332
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 328
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 296
11-C-choline PET/CT imaging for localization of recurrent prostate cancer 294
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 289
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 281
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 277
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 272
Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy 270
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 268
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 265
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 262
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 255
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 255
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 249
The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer 249
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 243
miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma 238
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 238
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 237
The carotid plaque as paradigmatic case of site-specific acceleration of agingprocess: The microRNAs and the inflammaging contribution 236
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 235
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 234
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 233
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 232
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 232
Pathological post-mortem findings in lungs infected with SARS-CoV-2 231
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 229
PATOLOGIA - Fondamenti Clinicopatologici in medicina Edizione Italiana a cura di Anna Gasperi-Campani e Walter F. Grigioni 228
The peculiar aging of human liver: A geroscience perspective within transplant context 228
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 228
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 227
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 227
NUCLEOFECTION IS AN EFFICIENT NON-VIRAL TRANSFECTION TECHNIQUE FOR HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS. 226
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 224
Autoimmune Atrophic Gastritis: A Clinical Review 220
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study 219
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 216
Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: Results from a case report 216
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 215
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 214
Increased plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness 214
Acute cellular rejection monitoring after interstinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. 213
The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes 213
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 212
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 212
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 211
Liver and intestinal protective effects of Castanea sativa Mill. bark extract in high-fat diet rats 210
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 209
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 205
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 204
A new diagnostic technique in detecting early phases of breast cancer 204
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 203
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 202
Differential expression of perilipin 2 and 5 in human skeletal muscle during aging and their association with atrophy-related genes 201
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 201
46‐kg abdominal tumor misdiagnosed as obesity: Unveiling healthcare bias due to obesity stigma 198
[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial 198
Donors risk assessment in transplantation: From the guidelines to their real-world application 197
Basi scientifiche per la definizione delle linee guida in ambito clinico per l’epatocarcinoma. 197
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 197
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 196
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 195
In Reply 195
Routine blood tests? Helping you live(r) longer! 193
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 192
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 192
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors 191
Evaluation of cytokines and matrix metalloproteinases genes expression in genital organs after vaginal exposure to Chlamydia muridarum 190
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience 189
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma? 188
Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production 187
Diffuse calcifications protect carotid plaques regardless of the amount of neoangiogenesis and related histological complications 187
Nivolumab-induced cholangitic liver disease: A novel form of serious liver injury 187
Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections 186
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. 185
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 185
Pancreatic involvement in systemic sarcoidosis. A case report. 184
Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. 184
Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations 184
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 184
The role of 3D microenvironmental organization in MCF-7 epithelial–mesenchymal transition after 7 culture days 183
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 183
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer 181
11C-Choline PET/TC for tumor localization of primary prostate cancer: comparison with 3-D proton MR spectroscopic imaging using radical prostatectomy specimen as standard of reference 181
ORGAN-SPECIFIC BIOMARKERS OF HUMAN AGING: THE CASE OF LIVER 181
The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study 181
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 181
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 180
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 179
Lack of recurrence of malignant atrophic papulosis of Degos in multivisceral transplant: insights into possible pathogenesis? 178
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 178
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 177
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 177
Totale 23.067
Categoria #
all - tutte 139.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.111 0 0 0 0 0 0 0 0 0 0 0 1.111
2021/20225.205 608 186 283 400 412 239 146 355 191 319 1.274 792
2022/20235.987 624 849 328 809 382 489 178 377 1.020 153 441 337
2023/20241.517 142 288 100 167 109 294 63 90 52 74 68 70
2024/20257.072 331 1.117 642 514 978 387 443 235 132 555 357 1.381
2025/202619.167 1.790 2.082 1.637 1.327 1.749 899 2.366 614 3.438 1.293 1.384 588
Totale 50.734